Biotech

All Articles

Novo inks $600M NanoVation deal to research hereditary medications ex-liver

.Novo Nordisk is proceeding its own press right into genetic medicines, accepting compensate NanoVat...

Innovent web links cytokine to colorectal cancer cells actions

.Innovent Biologics has created the case that its gate inhibitor-cytokine combination protein posses...

Merck, Daiichi ADC strikes target in stage 3 lung cancer research

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens artificial intelligence center with collab to select cancer targets

.5 months after Rakovina Therapeutics rotated toward artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism medication favorites in phase 3, endangers BioMarin

.Ascendis Pharma has actually become a potential risk to BioMarin's Voxzogo, reporting phase 3 growt...

Despite ph. 3 miss, Alkeus finds path in advance for eye disease property

.Though Alkeus Pharmaceuticals' dental eye disease property fell short to dramatically lower geograp...

Kairos goes public with $6M IPO to money trials of cancer cells medicine

.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually easy to miss a smaller...

Vaccine and also Keytruda combo reliable in squamous tissue cancer

.Immune gate inhibitors are the superheroes of cancer cells treatment. Drugs like Bristol Myers Squi...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings and...

Regeneron's Opdualag competitor reveals 57% reaction price

.Regeneron is back along with long-term follow-up for its LAG-3 inhibitor and PD-1 inhibitor combo i...